CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Corrigendum: Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study
Kyunghwan Oh, Hee Seung Hong, Nam Seok Ham, Jungbok Lee, Sang Hyoung Park, Suk-Kyun Yang, Hyuk Yoon, You Sun Kim, Chang Hwan Choi, Byong Duk Ye,
Intest Res. 2023;21(2):273-273.   Published online April 28, 2023
DOI: https://doi.org/10.5217/ir.2021.00173.e

Excel Download

Corrigendum: Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study
Intestinal Research. 2023;21(2):273-273   Crossref logo
Link1 Link2 Link3

Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study
Intestinal Research. 2023;21(1):137-147   Crossref logo
Link1 Link2 Link3

Real-world Short-term Effectiveness of Ustekinumab in Crohn’s Disease: Results from a Multicenter, Prospective Study in China
Inflammatory Bowel Diseases. 2022;28(Supplement_2):S42-S44   Crossref logo
Link1 Link2 Link3

P584 Systematic Review and Meta-analysis Evaluating the Real-World Effectiveness and Safety of Ustekinumab in Crohn’s Disease
Journal of Crohn's and Colitis. 2022;16(Supplement_1):i523-i523   Crossref logo
Link1 Link2

P636 Real-world clinical effectiveness and safety of vedolizumab and ustekinumab in biologic-naïve patients with Crohn’s disease: Results from the EVOLVE Expansion study
Journal of Crohn's and Colitis. 2023;17(Supplement_1):i768-i769   Crossref logo
Link1 Link2

P421 Real-world effectiveness and safety of vedolizumab induction therapy for Crohn’s disease in Poland – a prospective, observational POLONEZ II study considering patients reported outcomes
Journal of Crohn's and Colitis. 2023;17(Supplement_1):i550-i551   Crossref logo
Link1 Link2

Real-World Effectiveness and Safety of Ustekinumab in Elderly Crohn’s Disease Patients
Digestive Diseases and Sciences. 2021;67(7):3138-3147   Crossref logo
Link1 Link2 Link3

Real-World Evidence of the Effectiveness and Safety of Ustekinumab for the Treatment of Crohn’s Disease: Systematic Review and Meta-Analysis of Observational Studies
Journal of Clinical Medicine. 2022;11(14):4202   Crossref logo
Link1

P737 Ustekinumab induction effectiveness in Crohn’s disease in a real-life cohort
Journal of Crohn's and Colitis. 2020;14(Supplement_1):S590-S591   Crossref logo
Link1 Link2

Real-world effectiveness and safety of adalimumab in Korean patients with intestinal Behcet’s disease: a Korean Association for the Study of Intestinal Diseases (KASID) multicenter study
The Korean Journal of Internal Medicine. 2023;38(5):661-671   Crossref logo
Link1 Link2 Link3